PT - JOURNAL ARTICLE AU - Ma, Huiting AU - Chan, Adrienne K. AU - Baral, Stefan D. AU - Fahim, Christine AU - Straus, Sharon AU - Sander, Beate AU - Mishra, Sharmistha TI - Which curve are we flattening? The disproportionate impact of COVID-19 among economically marginalized communities in Ontario, Canada, was unchanged from wild-type to omicron AID - 10.1101/2022.10.24.22281104 DP - 2022 Jan 01 TA - medRxiv PG - 2022.10.24.22281104 4099 - http://medrxiv.org/content/early/2022/10/26/2022.10.24.22281104.short 4100 - http://medrxiv.org/content/early/2022/10/26/2022.10.24.22281104.full AB - Economically marginalized communities have faced disproportionately higher risks for infection and death from COVID-19 across Canada. It was anticipated that health disparities would dissipate over time and during subsequent waves. We used person-level surveillance and neighbourhood-level income data to explore, using Lorenz curves and Gini coefficients, magnitude of inequalities in COVID-19 hospitalizations and deaths over five waves of COVID-19 in Ontario, Canada (population 14 million) between February 26, 2020 and February 28, 2022. We found that despite attempts at equity-informed policies alongside fluctuating levels of public health measures, inequalities in hospitalizations and deaths by income remained at levels observed during the first wave - prior to vaccination, discussion or implementation of equity-informed policies - and despite rising levels of hybrid immunity. There was no change in the magnitude of inequalities across all waves evaluated. Our findings indicate that interventions did not sufficiently address differential exposure risks amplified at the intersections of household crowding and size, workplace exposures, and systemic barriers to prevention and care (including access to therapeutics). Equity and effectiveness of programs are inherently linked and ongoing evaluation of both is central to inform the public health response to future waves of COVID-19 and other rapidly emergent pandemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a Public Health Agency of Canada&#39s COVID-19 Immunity Task Force grant (#2021-HQ-000143), and the Canadian Institute of Health Research (grant no. VS1 - 175536). The funders did not have any role in the study design; collection, analysis, and interpretation of data; writing of the paper; and/or decision to submit for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of University of Toronto gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesReported COVID-19 cases were obtained from the Case and Contact Management Solutions and vaccination status were obtained from the provincial COVaxON Vaccination Management System via the Ontario COVID-19 Modelling Consensus Table and with approval from the University of Toronto Health Sciences Research Ethics Board (protocol no. 39253). The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred.